Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
05/2003
05/28/2003EP1015444B1 Pyrimidine derivatives and processes for the preparation thereof
05/28/2003CN1420908A Pyrimidine derivs. as hardness stabilizers
05/28/2003CN1420885A Therapeutically useful new salts of CCK inhibitors, process for preparation thereof and pharmaceutical preparations contg. them
05/28/2003CN1420884A 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
05/28/2003CN1420882A Substd. oxoazaheterocyclyl compounds
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1420875A Isothiazolecarboxylic acid derivs. and their use as microbicides
05/28/2003CN1420114A 2,3-disubstd. -4(3H)-quinazolones
05/28/2003CN1109679C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/27/2003US6570021 Intermediates for the preparation of 2-imidazolin-5-ones
05/27/2003US6570013 (4-oxo-(5-trifluoromethyl-benzothiazol-2-ylmethyl)-3,4-dihydro -phthalazin-1-yl)-acetic acid ethanolamine salt, useful for treating diabetic complication in a mammal
05/27/2003US6569882 Viricides; enzyme inhibitors
05/27/2003US6569880 Bis(benzimidazole) derivatives serving as potassium blocking agents
05/27/2003US6569878 Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
05/27/2003US6569874 Such as 2-acetylamino-4-(3-amidinophenyl)-5-((2'-amino-sulfonyl-(1,1')-biphen-4 -yl)aminocarbonyl)thiazole; for treatment of thromboembolic disorders
05/27/2003US6569873 Azolidines as beta-3 adrenergic receptor agonists
05/27/2003US6569856 Treatment of feeding disorders, obesity, bulimia nervosa, sexual/reproductive disorders, depression, epileptic seizure, cardiovascular disorders, sleep disturbances
05/27/2003US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity
05/27/2003US6569847 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease
05/27/2003US6569835 Hypolipidemics; treating obesity and disorders of lipid metabolism
05/27/2003CA2412624A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurogenerative diseases
05/27/2003CA2268847C Substituted oximes derivatives useful as neurokinin antagonists
05/22/2003WO2003042217A2 Method for making epothilone compounds by bioconversion with microorganisms
05/22/2003WO2003042211A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003WO2003042208A1 Pyrazole derivatives as psychopharmaceuticals
05/22/2003WO2003042207A1 Thiazolyl substituted triazoles as alk5 inhibitors
05/22/2003WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042198A1 Isothiazole derivatives
05/22/2003WO2003042194A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
05/22/2003WO2003042184A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
05/22/2003WO2003042183A1 Process for production of pyrazole compounds
05/22/2003WO2003042181A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivatives or salts thereof
05/22/2003WO2003042178A1 Novel piperidine derivatives as modulators of chemokine receptors
05/22/2003WO2003042177A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042175A1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
05/22/2003WO2003042147A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
05/22/2003WO2003041714A1 Benzotriazepines as gastrin and cholecystokinin receptor ligands
05/22/2003WO2003041711A1 Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor
05/22/2003WO2003041644A2 Method to treat cystic fibrosis
05/22/2003WO2003024943A3 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis
05/22/2003WO2003022280A3 3-glyoxlylamideindoles for treating cancer
05/22/2003WO2003020699A3 Tyrosine kinase inhibitors
05/22/2003WO2002100327A3 Substituted 1-benzazepines and derivatives thereof
05/22/2003WO2002096362A3 Method for treating fibrotic diseases or other indications vi
05/22/2003US20030096849 For therapy of cancer, ras oncogene-dependent tumors, such as cancers of the pancreas, colon, bladder, and thyroid
05/22/2003US20030096846 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
05/22/2003US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
05/22/2003US20030096817 Inhibiting mammalian protein kinases (p38) with (2,6-difluoro-phenyl)-(5-iodo-pyridin-2-yl)amine for treatment of cardiovascular disorders
05/22/2003US20030096816 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096765 Aromatic esters; cytotoxic agents; antitumor agents
05/22/2003US20030096737 Caspase inhibitors and uses thereof
05/22/2003US20030096715 Lubricant composition, method for using and preparing thereof and molecular complex compound used for the same
05/22/2003US20030096381 Production of polyketides
05/22/2003CA2467267A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003CA2467115A1 Process for production of pyrazole compounds
05/22/2003CA2467081A1 Pyrazole derivatives as psychopharmaceuticals
05/22/2003CA2466971A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
05/22/2003CA2466955A1 Benzotriazepines as gastrin and cholecystokinin receptor ligands
05/22/2003CA2466665A1 Method to treat cystic fibrosis
05/22/2003CA2465861A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
05/22/2003CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2464347A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2464069A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
05/21/2003EP1311504A1 Tetrazolyl-phenyl acetamide glucokinase activators
05/21/2003EP1311502A1 Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders
05/21/2003EP1311495A2 Catalytic process for the preparation of thiazole derivatives
05/21/2003EP1311494A1 Continuous process for the preparation of pesticidal chlorothiazoles
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311480A1 New amidino derivatives and their use as thrombin inhibitors
05/21/2003EP0971709B1 Novel compounds useful as neuro-protective agents
05/21/2003EP0874827B1 Quinoline derivatives as nk3 antagonists
05/21/2003CN1419547A Compounds exhibiting thrombopoietin receptor agaonism
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419542A Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides 403
05/21/2003CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
05/21/2003CN1419452A Synergistic methods and compositions for treating cancer
05/21/2003CN1109026C Sidechain-beering taxanes like compounds
05/21/2003CN1109022C Arylalkanoyl pyridazines derivatives, its preparation method, medicine comprising samd and use thereof
05/20/2003US6566521 Bidentate phosphine ligands; for preparing linear aldehydes by hydroformylating internal olefins using said phosphine ligands
05/20/2003US6566380 For therapy of cardiac arrhythmias
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003US6566376 Diphenyl-piperidine derivative
05/20/2003US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer
05/20/2003US6566364 Linear or cyclic ureas
05/20/2003US6566358 Cyclocarbamate derivatives as progesterone receptor modulators
05/20/2003US6566340 Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
05/15/2003WO2003040147A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________
05/15/2003WO2003040142A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
05/15/2003WO2003040131A1 Aminopyrimidines and pyridines
05/15/2003WO2003040129A1 Halogenated nitrobutadienes for controlling animal pests
05/15/2003WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003WO2003040118A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003WO2003040117A1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
05/15/2003WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003WO2003040110A1 Triazole derivatives as cyclooxygenase (cox) inhibitors
1 ... 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 ... 628